ARCHIVES

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

This article is from The Cancer Letter archive.

Vol. 30 No. 31 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

In Brief: Weicker Heads New Group For More Spending On Medical Research; Committee Oks Sullivan

March 3, 1989

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

Proposed Regulations for Center Grants In Federal Register

October 29, 1976